How all sponsors can benefit from a synchronized outsourcing strategy
Read the whitepaperUsing enhanced digital content and design
Read the whitepaperMethodologies to support HTA decision making
Read the whitepaperRare disease drug development is challenging due to limited info on patient distribution, change in disease progression and relevant outcomes to define treatment benefits.
9 May 2022 - Register today
Access webinar recording.
Access webinar recording.
Visit our webinar channel to access other recent webinars.
Expertise in mission-critical pricing, market access, and reimbursement.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
From recruitment of a single clinical professional to managing entire global functions.
FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.